Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
126 participants
INTERVENTIONAL
2003-02-28
2007-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Daily Sedative Interruption in Critically Ill Patients Being Managed With a Sedation Protocol
NCT00298493
Early Goal-Directed Sedation Compared With Standard Care in Mechanically Ventilated Critically Ill Patients
NCT01728558
Inhalational Sedation and Mechanical Power
NCT05559970
Precision Sedation in Intensive Care
NCT06991777
Effectiveness of Sedation Management in an Australian Intensive Care Unit
NCT00202319
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
midazolam with 2 different levels of sedation scores
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Chronic renal failure, liver failure
* Allergy to benzodiazepines or morphine
* Drug overdose
* Pregnancy
* Non-cooperative
* Treatment with HIV protease inhibitors or erythromycin
* Refusal of consent
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Swiss National Science Foundation
OTHER
University Hospital, Geneva
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Miriam M Treggiari, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Geneva
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Geneva University Hospitals
Geneva, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2002DR2266
Identifier Type: -
Identifier Source: secondary_id
3200-068312
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.